Germany· DE-A57-3f1405afc3c1803b
Deferasirox Basics
A deferasirox product containing deferasirox, registered in Germany by Basics Gmbh. The same ATC class is registered in 18 of our 19 countries.
Checked against EMA Article 57 (European Union) on
Informational only — not a medical device.
Where it is registered
Deferasirox is registered in 18 of 19 countries.
Countries holding a registration under ATC V03AC03 (deferasirox), each read from that country’s own register.
- This record: Germany, from EMA Article 57 (European Union)
- 10 of them publish a price we can compare per daily dose
Deferasirox · ATC V03AC03
18 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of deferasirox costs, country by country.
Normalised to the WHO defined daily dose (0.98 g), the median price runs from $24.11 in Spain to $59.57 in Switzerland — a ×2.5 gap.
- 4 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Deferasirox · price per daily dose (0.98 g)
USD · FX 28 Sept 2026
- CH Switzerland$59.57
- IT Italy$43.21
- FR France$27.16
- ES Spain$24.11
The record
At a glance
EMA Article 57 (European Union)- Active substance
- Deferasirox
- Manufacturer
- Basics Gmbh
- Country
- Germany (DE)
- ATC code
- V03AC03
- ATC class
- Deferasirox
- Defined daily dose
- 0.98 g, O
- Reimbursed
- Not published by this register
- Source register
- EMA Article 57 (European Union)
- Last checked
- September 30, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
616 interactions on record for deferasirox.
Graded by severity as the source publishes them — 205 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Deferasirox · interactions on record
616 records
- 205 severe
- 399 moderate
- 12 minor
Most severe, free to view
- NeomycinA07AA01severe
- StreptomycinA07AA04severe
- Polymyxin BA07AA05severe
- Amphotericin BA07AA07severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Deferasirox in 17 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaDEFERASIROX ACCORDAccord Healthcare S.L.U., Barcelona
- United StatesdeferasiroxZydus Pharmaceuticals USA Inc.
- NetherlandsDeferasirox Abdi 180 mg filmomhulde tablettenAbdi Farma GmbH
- United KingdomDeferasirox 180mg tabletsAmarox Ltd
- SwedenDeferasirox 1A Farma 180 mg Filmdragerad tablett1A Farma A/S
- SpainDEFERASIROX ABDI 180 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFGAbdi Farma Gmbh
- SwitzerlandDeferasirox Accord
- CanadaAPO-DEFERASIROXAPOTEX INC
Authorised across Europe · EMA
The same active substance is authorised in 25 EEA countries. Names it is sold under:
- Austria · Deferasirox G.L., Deferasirox Ratiopharm
- Belgium · Deferasirox Ab, Deferasirox Ab Ab
- Bulgaria · Deferasirox Synthon, Ziadex
- Cyprus · Deferasirox Msn, Issoferrol
- Czechia · Deferasirox Auxpharma, Deferasirox Glenmark
- Denmark · Deferasirox Deferasirox "jubilant", Deferasirox Glenmark
- Spain · Deferasirox Abdi, Deferasirox Aurovitas
- Finland · Deferasirox Glenmark, Deferasirox Stada
- France · Deferasirox Arrow, Deferasirox Bgr
- United Kingdom (Northern Ireland) · Deferasirox Abdi Farma, Deferasirox Amarox
- Greece · Deferasirox Pharmathen, Deferasirox Rafarm
- Croatia · Deferasiroks Pliva, Deferasiroks Umedica
- Hungary · Deferasirox Msn, Deferasirox Pharmascience
- Iceland · Deferasirox Accord, Deferasirox Medical Valley
- Italy · Deferasirox Abdi, Deferasirox Aurobindo
- Liechtenstein · Deferasirox Accord, Deferasirox Mylan
- Latvia · Deferasirox Umedica
- Malta · Deferasirox Pharos
- Netherlands · Deferasirox Abdi, Deferasirox Amarox
- Norway · Deferasirox Accord, Deferasirox Medical Valley
- Poland · Deferasirox Msn, Exferana
- Portugal · Deferasirox 180 Mg, Deferasirox 360 Mg
- Romania · Deferasirox Msn Laboratories, Deferasirox Sanexcel
- Sweden · Deferasirox Glenmark, Deferasirox Jubilant
- Slovakia · Deferasirox, Deferasirox Glenmark
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of EMA Article 57 (European Union). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d3970437-0e38-48c1-b722-e9ba7bca092d GET /v1/drugs/d3970437-0e38-48c1-b722-e9ba7bca092d?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"pzn": null,
"route": "Oral Use",
"source": "ema_art57_de",
"ma_number": null,
"substance": "Deferasirox",
"atc_from_source": null,
"authorisation_country": "Germany"
}See everything about deferasirox.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.